Abstract
A 79-year-old man without a history of diabetes underwent orchiectomy for prostate cancer. Eight months after the operation, he suffered severe deterioration of visceral fat deposition, fatty liver and diabetes. Treatment for diabetes with canagliflozin and dulaglutide resulted in improvement in his glycemic control, visceral fat and fatty liver. Visceral fat-dominant deposition, which differs from the typical course after androgen deprivation therapy, may have been associated with severe exacerbation of diabetes and fatty liver. Glycemic management with a sodium glucose cotransporter 2 (SGLT2) inhibitor and glucagon-like peptide (GLP)-1 receptor agonist may help improve the glucose metabolism, visceral fat deposition and fatty liver after orchiectomy.
Original language | English |
---|---|
Pages (from-to) | 2281-2285 |
Number of pages | 5 |
Journal | Internal Medicine |
Volume | 59 |
Issue number | 18 |
DOIs | |
Publication status | Published - Jun 2020 |
Keywords
- Diabetes mellitus
- Fatty liver
- GLP-1 receptor agonist
- Orchiectomy
- SGLT2 inhibitor
- Visceral fat
ASJC Scopus subject areas
- Internal Medicine